메뉴 건너뛰기
Lupus
Volumn 8, Issue 8, 1999, Pages 620-626
Equivalence trials in SLE research: Issues to consider
Author keywords

Clinical trials; Equivalence trials; Statistical methods; Systemic lupus erythematosus
Indexed keywords

CLINICAL TRIAL; HUMAN; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; TREATMENT PLANNING;
EID: 0032758557     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120399680411308     Document Type: Review
Times cited : (15)
References (18)
  • 1
    • 0032528867 scopus 로고    scopus 로고
    • Practical issues in equivalence trials
    • Ebbutt AF, Frith L. Practical issues in equivalence trials. Stat Med 1998: 17: 1691-1701.
    • (1998) Stat Med , vol.17 , pp. 1691-1701
    • Ebbutt, A.F.1    Frith, L.2
  • 2
    • 0032529072 scopus 로고    scopus 로고
    • Therapeutic equivalence investigations: Statistical considerations
    • Rohmel J. Therapeutic equivalence investigations: statistical considerations. Stat Med 1998; 17: 1703-1714.
    • (1998) Stat Med , vol.17 , pp. 1703-1714
    • Rohmel, J.1
  • 3
    • 0029987569 scopus 로고    scopus 로고
    • Trials to assess equivalence: The importance of rigorous methods
    • Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods. BMJ 1996; 313: 36-39.
    • (1996) BMJ , vol.313 , pp. 36-39
    • Jones, B.1    Jarvis, P.2    Lewis, J.A.3    Ebbutt, A.F.4
  • 4
    • 0030814329 scopus 로고    scopus 로고
    • Equivalence trials
    • Ware JH, Amman EM. Equivalence trials. N Eng J Med 1997; 337: 1159-1161.
    • (1997) N Eng J Med , vol.337 , pp. 1159-1161
    • Ware, J.H.1    Amman, E.M.2
  • 5
    • 0020308864 scopus 로고
    • Proving the null hypothesis in clinical trials
    • Blackwelder WC. Proving the null hypothesis in clinical trials. Control Clin Trials 1982; 3: 345-353.
    • (1982) Control Clin Trials , vol.3 , pp. 345-353
    • Blackwelder, W.C.1
  • 6
    • 0019576616 scopus 로고
    • Comparison of different methods for decisionmaking in bioequivalence assessment
    • Mandallaz D, Mau J. Comparison of different methods for decisionmaking in bioequivalence assessment. Biometics 1981; 37: 213-222.
    • (1981) Biometics , vol.37 , pp. 213-222
    • Mandallaz, D.1    Mau, J.2
  • 7
    • 0021397596 scopus 로고
    • On testing for bioequivalence
    • Rocke DM. On testing for bioequivalence. Biometrics 1984; 40: 225-230.
    • (1984) Biometrics , vol.40 , pp. 225-230
    • Rocke, D.M.1
  • 8
    • 0016232744 scopus 로고
    • Symmetric confidence intervals for bioequivalence trials
    • Westlake WJ. Symmetric confidence intervals for bioequivalence trials. Biometrics 1974; 30: 319-327.
    • (1974) Biometrics , vol.30 , pp. 319-327
    • Westlake, W.J.1
  • 9
    • 0025633361 scopus 로고
    • Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk
    • Farrington CP, Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat Med 1990; 9: 1447-1454.
    • (1990) Stat Med , vol.9 , pp. 1447-1454
    • Farrington, C.P.1    Manning, G.2
  • 10
    • 0030853121 scopus 로고    scopus 로고
    • Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes
    • Shih JW, Zhao PL. Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes. Stat Med 1997; 16: 1913-1923.
    • (1997) Stat Med , vol.16 , pp. 1913-1923
    • Shih, J.W.1    Zhao, P.L.2
  • 11
    • 0029128443 scopus 로고
    • Comparison of tests and sample size formulae for proving therapeutic equivalence based on the difference of binomial probabilities
    • Roebruck P, Kuhn A. Comparison of tests and sample size formulae for proving therapeutic equivalence based on the difference of binomial probabilities. Stat Med 1995; 14: 1583-1594.
    • (1995) Stat Med , vol.14 , pp. 1583-1594
    • Roebruck, P.1    Kuhn, A.2
  • 12
    • 0018103242 scopus 로고
    • Sample size requirements for evaluating a conservative therapy
    • Makuch R, Simon R. Sample size requirements for evaluating a conservative therapy. Cancer Treat Rep 1978; 62: 1037-1041.
    • (1978) Cancer Treat Rep , vol.62 , pp. 1037-1041
    • Makuch, R.1    Simon, R.2
  • 13
    • 0017643592 scopus 로고
    • Significance testing to establish equivalence between treatments, with special reference to data in the form of 2 × 2 tables
    • Dunnett CW, Gent, M. Significance testing to establish equivalence between treatments, with special reference to data in the form of 2 × 2 tables. Biometric 1977; 33: 593-602.
    • (1977) Biometric , vol.33 , pp. 593-602
    • Dunnett, C.W.1
  • 14
    • 0025252410 scopus 로고
    • Evaluation of active control trials in AIDS
    • Fleming TR. Evaluation of active control trials in AIDS. J Acquir Immune Defic Synd 1990; 3: s82-s87.
    • (1990) J Acquir Immune Defic Synd , vol.3
    • Fleming, T.R.1
  • 15
    • 0019362251 scopus 로고
    • Introduction to sample size determination and power analysis for clinical trials
    • Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials 1981; 2: 93-113.
    • (1981) Control Clin Trials , vol.2 , pp. 93-113
    • Lachin, J.M.1
  • 16
    • 0025051476 scopus 로고
    • Planning and monitoring of equivalence studies
    • Durrleman S, Simon R. Planning and monitoring of equivalence studies. Biometrics 1990; 46: 329-336.
    • (1990) Biometrics , vol.46 , pp. 329-336
    • Durrleman, S.1    Simon, R.2
  • 18
    • 0027199595 scopus 로고
    • Clinical and statistical issues in therapeutic equivalence trials
    • Garbe E, Rohmel J, Gundert-Remy U. Clinical and statistical issues in therapeutic equivalence trials. Eur J Clin Pharmacol 1993; 45: 1-7.
    • (1993) Eur J Clin Pharmacol , vol.45 , pp. 1-7
    • Garbe, E.1    Rohmel, J.2    Gundert-Remy, U.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.